Patents by Inventor Peter Terness

Peter Terness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIC therapy for specific immunosuppression in transplantation
    Patent number: 11554139
    Abstract: The present invention relates to pharmaceutical compositions with isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs) as well as such pharmaceutical compositions for use in the prevention and/or treatment of organ or cell graft rejection in a human graft recipient.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: January 17, 2023
    Assignees: TOLEROGENIXX GMBH, UNIVERSITÄT HEIDELBERG
    Inventors: Christian Morath, Anita Schmitt, Matthias Schaier, Gerhard Opelz, Peter Terness, Christian Kleist, Volker Daniel, Caner Süsal, Michael Schmitt, Martin Zeier
  • MIC THERAPY FOR SPECIFIC IMMUNOSUPPRESSION IN TRANSPLANTATION
    Publication number: 20220118009
    Abstract: The present invention relates to pharmaceutical compositions with isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs) as well as such pharmaceutical compositions for use in the prevention and/or treatment of organ or cell graft rejection in a human graft recipient.
    Type: Application
    Filed: May 17, 2019
    Publication date: April 21, 2022
    Inventors: Christian MORATH, Anita SCHMITT, Matthias SCHAIER, Gerhard OPELZ, Peter TERNESS, Christian KLEIST, Volker DANIEL, Caner SÜSAL, Michael SCHMITT, Martin ZEIER
  • Immunosuppressive blood cells and methods of producing the same
    Patent number: 11123368
    Abstract: The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: September 21, 2021
    Assignee: Universitatsklinikum Heidelberg
    Inventors: Peter Terness, Gerhard Opelz, Helmut Simon, Sandra Ehser, Christian Kleist, Flavius Sandra-Petrescu, Mircea Iancu, Lucian Jiga, Jing-Jing Chuang, Thilo Oelert
  • IMMUNOSUPPRESSIVE BLOOD CELLS AND METHODS OF PRODUCING THE SAME
    Publication number: 20170319619
    Abstract: The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: May 19, 2017
    Publication date: November 9, 2017
    Applicant: Universitatsklinikum Heidelberg
    Inventors: Peter TERNESS, Gerhard OPELZ, Helmut SIMON, Sandra EHSER, Christian KLEIST, Flavius SANDRA-PETRESCU, Mircea IANCU, Lucian JIGA, Jing-Jing CHUANG, Thilo OELERT
  • IMMUNOSUPPRESSIVE BLOOD CELLS AND METHODS OF PRODUCING THE SAME
    Publication number: 20150132326
    Abstract: The present invention refers to a method of producing immunosuppressive blood cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: November 7, 2014
    Publication date: May 14, 2015
    Applicant: Universitatsklinikum Heidelberg
    Inventors: Peter TERNESS, Gerhard OPELZ, Helmut SIMON, Sandra EHSER, Christian KLEIST, Flavius SANDRA-PETRESCU, Mircea IANCU, Lucian JIGA, Jing-Jing CHUANG, Thilo OELERT
  • IMMUNOSUPPRESSIVE BLOOD CELLS AND METHODS OF PRODUCING THE SAME
    Publication number: 20110223145
    Abstract: The present invention refers to a method of producing immunosuppressive blood cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: June 30, 2009
    Publication date: September 15, 2011
    Inventors: Peter Terness, Gerhard Opelz, Helmut Simon, Sandra Ehser, Christian Kleist, Flavius Sandra-Petrescu, Mircea Iancu, Lucian Jiga, Jing-Jing Chuang, Thilo Oelert
  • Gpi anchored glycoprotein aca as a novel tumor marker
    Publication number: 20060276375
    Abstract: Described is a GPI-anchored surface glycoprotein having a GPI-anchor which is characterized by a non-acetylated inositol ring and diacyl glycerol as lipid tail of the anchor. A particular glycoprotein of the invention, ACA, is strongly expressed in melanoma cells, some leukemia cells and other tumor cells, thus, is an useful marker for diagnosis of said tumors. The invention also relates to salts, functional derivatives and active fractions of ACA having substantially the same spectrum of biological activities of ACA. The invention also relates to a process for the purification of ACA, to its cloning and its production by recombinant DNA techniques. It further relates to diagnostic compositions comprising an anti-ACA-antibody or an oliognucleotide probe capable of hybridizing to ACA-mRNA and to pharmaceutical compounds containing a compound capable of reducing the expression of ACA or the activity of the protein.
    Type: Application
    Filed: August 6, 2003
    Publication date: December 7, 2006
    Inventors: Peter Terness, Zorica Becker-Kojic
  • Immuno-suppressive material and process for preparing same
    Patent number: 5004604
    Abstract: An immuno-suppressor is described in the form of an immuno-suppressor serum and/or an IS-IgG extracted from this serum, produced by immunisation of an animal with antibody-covered cells; also described is the process for making said immuno-suppressor and its use for suppressing the humoral and/or cellular immune response.
    Type: Grant
    Filed: March 25, 1988
    Date of Patent: April 2, 1991
    Assignee: Fresenius A. G.
    Inventors: Peter Terness, Gerhard Opelz